Literature DB >> 23329349

The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis.

Thomas Hyphantis1, Konstantinos Kotsis, Niki Tsifetaki, Francis Creed, Alexandros A Drosos, André F Carvalho, Paraskevi V Voulgari.   

Abstract

Anxiety and depressive symptoms as well as cognitive variables are important in determining outcome in rheumatic diseases. We aimed to compare psychological distress symptoms and illness perceptions in ankylosing spondylitis (AS) and rheumatoid arthritis (RA) and to test whether their associations with health-related quality of life (HRQoL) were similar in these rheumatologic disorders. In 55 AS and 199 RA patients, we administered the Patient Health Questionnaire (PHQ-9), the Symptom Check-List and the Brief-Illness Perception Questionnaire to assess psychological variables and the World Health Organization Quality of Life Instrument, Short Form to assess HRQoL. We used hierarchical regression analyses to determine the associations between psychological variables and HRQoL after adjusting for demographic variables and disease parameters. The prevalence of clinically significant depressive symptoms (PHQ-9 ≥ 10) was 14.8 % in AS and 25.1 % in RA patients, but adjustment for demographics rendered these differences in depressive symptoms' severity non-significant. Psychological distress levels and HRQoL were similar in both disorders. Illness concern (b = -0.37) was the only significant independent correlate of physical HRQoL in AS. In RA, depression (b = -0.25), illness concern (b = -0.14) and worries about the consequences of the disease (b = -0.31) were the independent correlates of physical HRQoL. These findings suggest that cognitive variables are important correlates of HRQoL in AS, whereas in RA depressive symptoms and illness perceptions equally contribute to HRQoL. Our data encourage the design of psychotherapeutic trials targeting disease-related cognitions in AS in an attempt to improve patient's physical HRQoL.

Entities:  

Mesh:

Year:  2013        PMID: 23329349     DOI: 10.1007/s10067-012-2162-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

1.  The World Health Organization WHOQOL-100: tests of the universality of Quality of Life in 15 different cultural groups worldwide.

Authors:  M Power; A Harper; M Bullinger
Journal:  Health Psychol       Date:  1999-09       Impact factor: 4.267

2.  Psychological screening in rheumatoid arthritis.

Authors:  J C Parker; S P Buckelew; K L Smarr; K L Buescher; N C Beck; R G Frank; S K Anderson; S E Walker
Journal:  J Rheumatol       Date:  1990-08       Impact factor: 4.666

3.  The brief illness perception questionnaire.

Authors:  Elizabeth Broadbent; Keith J Petrie; Jodie Main; John Weinman
Journal:  J Psychosom Res       Date:  2006-06       Impact factor: 3.006

4.  Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

Authors:  A Zink; J Braun; J Listing; J Wollenhaupt
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

5.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

6.  Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.

Authors:  Koen Demyttenaere; Durisala Desaiah; Claude Petit; Jens Croenlein; Stephan Brecht
Journal:  Curr Med Res Opin       Date:  2011-12-22       Impact factor: 2.580

7.  Psychological status in Moroccan patients with ankylosing spondylitis and its relationships with disease parameters and quality of life.

Authors:  Jinane Hakkou; Samira Rostom; Nawal Aissaoui; Kenza Rhzioual Berrada; Redouane Abouqal; Rachid Bahiri; Najia Hajjaj-Hassouni
Journal:  J Clin Rheumatol       Date:  2011-12       Impact factor: 3.517

8.  Problem elicitation to assess patient priorities in ankylosing spondylitis and fibromyalgia.

Authors:  C Bakker; S van der Linden; M van Santen-Hoeufft; P Bolwijn; A Hidding
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

9.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

10.  Quality of life and illness perception in working and sick-listed chronic RSI patients.

Authors:  Judith K Sluiter; Monique H W Frings-Dresen
Journal:  Int Arch Occup Environ Health       Date:  2007-07-19       Impact factor: 3.015

View more
  25 in total

1.  Divergent perceptions in health-related quality of life between family members and patients with rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis.

Authors:  Cesar Ramos-Remus; José Dionisio Castillo-Ortiz; Carlos Sandoval-Castro; Francisco Paez-Agraz; Adriana Sanchez-Ortiz; Francisco Javier Aceves-Avila
Journal:  Rheumatol Int       Date:  2014-05-24       Impact factor: 2.631

2.  [Depression and rheumatism: options for measuring depression].

Authors:  M Englbrecht; J Wendler; R Alten
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

Review 3.  Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways.

Authors:  John A Sturgeon; Patrick H Finan; Alex J Zautra
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

4.  Contribution of the self-regulation model to understanding the health related quality of life of rheumatoid arthritis patients.

Authors:  Shiri Shinan-Altman; Shiran Afuta-Goldstein
Journal:  Qual Life Res       Date:  2019-10-01       Impact factor: 4.147

5.  Adaptation to inflammatory rheumatic disease: Do illness representations predict patients' physical functioning over time? A complex relationship.

Authors:  Evangelos C Karademas; Georgia Dimitraki; Emmanouil Papastefanakis; Georgia Ktistaki; Argyro Repa; Irini Gergianaki; George Bertsias; Prodromos Sidiropoulos; Panagiotis Simos
Journal:  J Behav Med       Date:  2017-09-21

6.  Olfactory dysfunction in spondyloarthritis.

Authors:  Esin Yalcinkaya; Mustafa Mert Basaran; Hakan Erdem; Murat Kocyigit; Aytug Altundag; Thomas Hummel
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-05       Impact factor: 2.503

7.  Impulsivity and ankylosing spondylitis: Is there a relationship?

Authors:  Fatma Gül Yurdakul; Yeşim Garip Çimen; Rezan Koçak Ulucaköy; Şahide Eda Almaz; Aslı Çalışkan Uçkun; Hatice Bodur
Journal:  Turk J Phys Med Rehabil       Date:  2018-10-09

8.  Profiling Behavioral and Psychological Symptoms in Children Undergoing Treatment for Spondyloarthritis and Polyarthritis.

Authors:  Anne McHugh; Avis Chan; Carolyn Herrera; Jennifer M Park; Imelda Balboni; Dana Gerstbacher; Joyce J Hsu; Tzielan Lee; Margo Thienemann; Jennifer Frankovich
Journal:  J Rheumatol       Date:  2022-02-01       Impact factor: 5.346

9.  The relationship of illness perceptions with demographic features, pain severity, functional capacity, disability, depression, and quality of life in patients with chronic low back pain.

Authors:  Özge Ünal; Yeşim Akyol; Berna Tander; Yasemin Ulus; Yüksel Terzi; Ömer Kuru
Journal:  Turk J Phys Med Rehabil       Date:  2019-11-22

10.  Are Illness Perceptions Associated With Disease Activity or Psychological Well-Being in Rheumatoid Arthritis? A Study With the Evidence of Confirmatory Factor Analysis.

Authors:  Yasemin Ulus; Berna Tander; Yeşim Akyol; Yüksel Terzi; Yeliz Zahiroğlu; Gökhan Sarisoy; Ayhan Bilgici; Ömer Kuru
Journal:  Arch Rheumatol       Date:  2017-04-04       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.